Determination of Predictive Genetic Markers of Toxicity After Hypofractionated Radiotherapy in Breast Cancer Patients Post-Conservative Surgery
HYPOPRONE
1 other identifier
observational
N/A
1 country
1
Brief Summary
The single shot partial breast irradiation (SSPBI) trial was designed as a prospective Phase II "single-arm study". The use of a single dose tumor bed is expected to be very effective in terms of tumor control, but it could increase the incidence of radiation induced erythema. Therefore, the investigators assumed that a decreased DNA repair capability, as well as a reduced detoxification of the damage caused by oxidative stress could explain the increased acute toxicity, i.e. a higher incidence of erythema after a single dose. For this reason the investigators decided to investigate SNPs of genes involved in antioxidant and DNA damage repair pathways such as GST, XRCC1, XRCC3 and RAD51. The investigators assumed an erythema rate of 20% and 54% in patient groups at low and high risk, respectively, (groups were identified based on the absence/presence of the above polymorphisms alone or in combination), thus the minimum sample size was 56 patients with α=0.05, 2-tailed test and a power of the study of 80%.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
Started May 2010
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
May 1, 2010
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2010
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2010
CompletedFirst Submitted
Initial submission to the registry
March 15, 2011
CompletedFirst Posted
Study publicly available on registry
March 16, 2011
CompletedMarch 16, 2011
December 1, 2010
7 months
March 15, 2011
March 15, 2011
Conditions
Keywords
Study Arms (1)
BC patients after SSPBI
breast cancer (BC) patients following single shot partial breast irradiation (SSPBI) after breast conservative surgery
Eligibility Criteria
breast cancer (BC) patients following single shot partial breast irradiation(SSPBI) after breast conservative surgery
You may qualify if:
- Age ≥ 48 years old with a life expectancy of at least 5 years
- Post-menopausal status
- Histologically proven, non lobular, adenocarcinoma of the breast
- Primary tumours ≤ 3 cm
- Negative surgical margins (≥ 2 mm)
- Negative sentinel nodes or \< 4 positive axillary nodes
- No extra-capsular extension
- No previous radiotherapy
You may not qualify if:
- multicentric disease
- extended intraductal component (EIC \> 25%)
- Paget's disease
- lobular adenocarcinoma
- distant metastases All the above criteria allow to identify patients at low risk of local recurrence.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Regina Elena NCI
Rome, Rome, 00144, Italy
Related Publications (3)
Falvo E, Strigari L, Citro G, Giordano C, Boboc G, Fabretti F, Bruzzaniti V, Bellesi L, Muti P, Blandino G, Pinnaro P. SNPs in DNA repair or oxidative stress genes and late subcutaneous fibrosis in patients following single shot partial breast irradiation. J Exp Clin Cancer Res. 2012 Jan 24;31(1):7. doi: 10.1186/1756-9966-31-7.
PMID: 22272830DERIVEDPinnaro P, Arcangeli S, Giordano C, Arcangeli G, Impiombato FA, Pinzi V, Iaccarino G, Soriani A, Landoni V, Strigari L. Toxicity and cosmesis outcomes after single fraction partial breast irradiation in early stage breast cancer. Radiat Oncol. 2011 Nov 11;6:155. doi: 10.1186/1748-717X-6-155.
PMID: 22079051DERIVEDFalvo E, Strigari L, Citro G, Giordano C, Arcangeli S, Soriani A, D'Alessio D, Muti P, Blandino G, Sperduti I, Pinnaro P. Dose and polymorphic genes xrcc1, xrcc3, gst play a role in the risk of articledeveloping erythema in breast cancer patients following single shot partial breast irradiation after conservative surgery. BMC Cancer. 2011 Jul 12;11:291. doi: 10.1186/1471-2407-11-291.
PMID: 21749698DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
Study Record Dates
First Submitted
March 15, 2011
First Posted
March 16, 2011
Study Start
May 1, 2010
Primary Completion
December 1, 2010
Study Completion
December 1, 2010
Last Updated
March 16, 2011
Record last verified: 2010-12